RARA CRAFT DATABASE for FDA Medical Devices
510(k)K193666

FDA DEVICE FACTS

Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy and Fentanyl) – Regular Cuff; Powder-Free Blue Nitrile Examination Gloves (Tested for use with Chemotherapy Drugs and Fentanyl) - Extended Cuff

Medline Industries, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 4, 2020PRODUCT CODELZA

Indications for use

A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemo Drugs Tested: Aresenic Trioxide 1 mg/ml (1,000 ppm) Azacitidine 25 mg/ml (25,000 ppm) Bendamustine 5 mg/ml (5,000 ppm) Bleomycin 15 mg/ml (15,000 ppm) Bortezomib 1 mg/ml (1,000 ppm) Busulfan 6 mg/ml (6,000 ppm) Carboplatin 10.0 mg/ml (10,000 ppm) Carfilzomib 2.0 mg/ml (2,000) Carmustine (BCNU) 3.3 mg/ml (3,300 ppm) Cetuximab 2.0 mg/ml (2,000) Cisplatin 1.0 mg/ml (1,000 ppm) Cyclophosphamide (Cytoxan) 20.0 mg/ml (20,000 ppm) Cytarabine 100 mg/ml (100,000 ppm) Cytovene 10 mg/ml (10,000 ppm) Dacarbazine (DTIC) 10.0 mg/ml (10,000 ppm) Daunorubicin 5 mg/ml (5,000 ppm) Decitabine 5 mg/ml (5,000 ppm) Docetaxel 10.0 mg/ml (10,000 ppm) Doxorubicin Hydrochloride 2.0 mg/ml (2,000 ppm) Epirubicin (Ellence) 2.0 mg/ml (2,000 ppm) Etoposide (Toposar) 20.0 mg/ml (20,000 ppm) Fludarabine 25 mg/ml (25,000 ppm) Fluorouracil 50.0 mg/ml (50,000 ppm) Fulvestrant 50.0 mg/ml (50,000 ppm) Gemcitabine (Gemzar) 38 mg/ml (38,000 ppm) Idarubicin 1 mg/ml (1,000 ppm) lfosfamide 50.0 mg/ml (50,000 ppm) Irinotecan 20.0 mg/ml (20,000 ppm) Mechlorethamine HCI 1.0 mg/ml (1,000 ppm) Melphalan 5 mg/ml (5,000 ppm) Methotrexate 25 mg/ml (25,000 ppm) Mitomycin C 0.5 mg/ml (500 ppm) Mitoxantrone 2.0 mg/ml (2,000 ppm) Oxaliplatin 2.0 mg/ml (2,000 ppm) Paclitaxel (Taxol) 6.0 mg/ml (6,000 ppm) Paraplatin 10 mg/ml (10,000 ppm) Pemetrexed Disodium 25.0 mg/ml (25,000 ppm) Pertuzumab 30 mg/ml (30,000 ppm) Raltitrexed 0.5 mg/ml (500 ppm) Breakthrough Time (Minutes) >240 >240 >240 >240 >240 >240 >240 >240 33.1 min >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 Retrovir 10.0 mg/ml (10,000 ppm) Rituximab 10 mg/ml (10,000 ppm) Temsirolimus 25.0 mg/ml (25,000 ppm) Thiotepa 10.0 mg/ml (10,000 ppm) Topotecan HCI 1.0 mg/ml (1,000 ppm) Trastuzumab 21.0 mg/ml (21,000 ppm) Trisonex 1 mg/ml (1,000 ppm) Vinblastine 1 mg/ml (1,000 ppm) Vincristine Sulfate 1.0 mg/ml (1,000 ppm) Vinorelbine 10 mg/ml (10,000 ppm) Zoledronic Acid 0.8 mg/ml (800 ppm) Fentanyl Citrate, 100mcg/2mL >240 >240 >240 69.2 min >240 >240 >240 >240 >240 >240 >240 62.0 min Please note that the following drug has low permeation time: Carmustine (BCNU) (3.3 mg/ml) 33.1 minutes CAUTION: Testing showed an average breakthrough time of33.l minutes with Carmustine >240 and 69.2 minutes with Thiotepa Thiotepa (THT) (10.0mg/ml) 69.2 minutes A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemotherapy Drug Tested Aresenic Trioxide 1 mg/ml Azacitidine 25 mg/ml Bendamustine 5 mg/ml Bleomycin 15 mg/m Bortezomib 1 mg/ml Busulfan 6 mg/ml Carfilzomib 2 mg/ml Carmustine (BCNU) 3 .3 mg/ml Cetuximab Cisplatin 1.0 mg/ml Cyclophosphamide (Cytoxan) 20.0 mg/ml Cytarabine Hydrochloride 100 mg/ml Cytovene 10 mg/ml Dacarbazine (DTIC) 10.0 mg/ml Daunorubicin 5 mg/ml Decitabine 5 mg/ml Docetaxel 10.0 mg/ml Doxorubicin Hydrochloride 2.0 mg/ml Epirubicin (Ellence) 2.0 mg/ml Etoposide (Toposar) 20.0 mg/ml Fludarabine 25 mg/ml Fluorouracil 50.0 mg/ml Fulvestrant 50.0 mg/ml Gemcitabine (Gemzar) 38 mg/ml Idarubicin 1 mg/ml lfosfamide 50.0 mg/ml Irinotecan 20.0 mg/ml Mechlorethamine HCI 1.0 mg/ml Melphalan 5 mg/ml Methotrexate 25.0 mg/ml Mitomycin C 0.5 mg/ml Mitoxantrone 2mg/ml Oxaliplatin 5.0 mg/ml Paclitaxel (Taxol) 6.0 mg/ml Paraplatin (Carboplatin) 10 mg/ml Pemetrexed Disodium 25.0 mg/ml Pertuzumab 3 0 mg/ml Raltitrexed 0.5 mg/ml Retrovir 10.0 mg/ml Breakthrough Time (in minutes) >240 >240 >240 >240 >240 >240 >240 59.4 min >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 Rituximab 10 mg/ml Temsirolimus 25.0 mg/ml Thiotepa 10.0 mg/ml Topotecan HCI 1.0 mg/ml Trastuzumab 21.0 mg/ml Trisonex 1 mg/ml Vinblastine 1 mg/ml Vincristine Sulfate 1.0 mg/ml Vinorelbine 10 mg/ml Zoledronic Acid 0.8 mg/ml Fentanyl Citrate, 100mcg/2mL >240 >240 68.2 min >240 >240 >240 >240 >240 >240 >240 167.8 min Please note that the following drug has low permeation time: Carmustine (BCNU) (3 .3 mg/ml) 59 .4 minutes CAUTION: Testing showed an average breakthrough time of 59.4 minutes with Carmustine >240 Thiotepa (THT) (10.0 mg/ml) 68.2 minutes and 68.2 minutes with Thiotepa

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026